Lonsurf 20 mg/8.19 mg film-coated tablets, Lonsurf 15 mg/6.14 mg film-coated tablets clinical trials

A phase 2 study of trifluridine/tipiracil in patients with ER-positive, HER2-negative advanced breast cancer that previously received chemotherapy (BOOG 2019-01 TIBET study)

This study looks at a new treatment called Lonsurf for women with advanced breast cancer that's grown despite other treatments. We want to see how many patients' cancer stops growing or shrinks after 8 weeks on Lonsurf.